Antifibrinolytic
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
|
WikiDoc Resources for Antifibrinolytic | |
|
Articles | |
|---|---|
|
Most recent articles on Antifibrinolytic Most cited articles on Antifibrinolytic | |
|
Media | |
|
Powerpoint slides on Antifibrinolytic | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Antifibrinolytic at Clinical Trials.gov Trial results on Antifibrinolytic Clinical Trials on Antifibrinolytic at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Antifibrinolytic NICE Guidance on Antifibrinolytic
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Antifibrinolytic Discussion groups on Antifibrinolytic Patient Handouts on Antifibrinolytic Directions to Hospitals Treating Antifibrinolytic Risk calculators and risk factors for Antifibrinolytic
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Antifibrinolytic | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Antifibrinolytics, such as aminocaproic acid (ε-aminocaproic acid) and tranexamic acid are used as inhibitors of fibrinolysis, which act by blocking the lysine-binding site on plasmin.
They are used in menorrhagia and bleeding tendency due to various causes.
External links
Antihemorrhagics (B02) | |
|---|---|
| Antifibrinolytics | amino acids (Aminocaproic acid, Tranexamic acid, Aminomethylbenzoic acid) - serpins (Aprotinin, Alfa1 antitrypsin, C1-inhibitor, Camostat) |
| Vitamin K | Phytomenadione - Menadione |
| Fibrinogen | Fibrinogen |
| Local hemostatics | Absorbable gelatin sponge - Oxidized cellulose - Tetragalacturonic acid hydroxymethylester - Adrenalone - Thrombin - Collagen - Calcium alginate - Epinephrine |
| Blood coagulation factors | IX - II - VII - X - VIII - Eptacog alfa - Nonacog alfa - Thrombin |
| Other systemic hemostatics | Etamsylate - Carbazochrome - Batroxobin |
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

